Basics |
Company: |
CNS Pharmaceuticals, Inc. Common Stock |
IPO Date: |
November 18, 2019 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$4.68M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.09 | 5.49%
|
Avg Daily Range (30 D): |
$0.09 | 6.95%
|
Avg Daily Range (90 D): |
$0.07 | 7.09%
|
Institutional Daily Volume |
Avg Daily Volume: |
.04M |
Avg Daily Volume (30 D): |
.66M |
Avg Daily Volume (90 D): |
.42M |
Trade Size |
Avg Trade Size (Sh.): |
12 |
Avg Trade Size (Sh.) (30 D): |
45 |
Avg Trade Size (Sh.) (90 D): |
36 |
Institutional Trades |
Total Inst.Trades: |
3 |
Avg Inst. Trade: |
$.73M |
Avg Inst. Trade (30 D): |
$M |
Avg Inst. Trade (90 D): |
$M |
Avg Inst. Trade Volume: |
M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$195.94
|
$-.25
|
$-6.72
|
Diluted EPS
|
$195.94
|
$-.25
|
$-6.72
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -17.06M
|
$ -5.61M
|
$ -2.53M
|
Operating Income / Loss
|
$ -17.08M
|
$ -5.63M
|
$ -2.53M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -.36M
|
$ M
|
$ M
|
PE Ratio
|
0.02
|
|
|
Splits |
Feb 21, 2025:
50:1
|
Jun 05, 2024:
50:1
|
Nov 29, 2022:
30:1
|
|